Sarepta Therapeutics to Announce Third Quarter 2016 Financial Results and Recent Corporate Developments on October 27, 2016
October 24 2016 - 8:30AM
Business Wire
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a
commercial-stage developer of innovative RNA-targeted therapeutics,
will report third quarter 2016 financial results before
the NASDAQ Global Market opens on Thursday, October
27, 2016. Subsequently, at 8:00 a.m., Eastern
Time, Edward Kaye, M.D., Sarepta’s chief executive
officer, Sandy Mahatme, Sarepta’s chief financial officer, and
Bo Cumbo, Sarepta’s senior vice president of global commercial
development will host a conference call to discuss third quarter
financial results and to provide a corporate update.
The conference call may be accessed by dialing (844) 534-7313
for domestic callers and (574) 990-1451 for international callers.
The passcode for the call is 7029987. Please specify to the
operator that you would like to join the "Sarepta Third Quarter
2016 Earnings Call." The conference call will be webcast live under
the investor relations section of Sarepta's website
at www.sarepta.com and will be archived there following
the call for 90 days. Please connect to Sarepta's website several
minutes prior to the start of the broadcast to ensure adequate time
for any software download that may be necessary.
About SareptaSarepta Therapeutics is a commercial-stage
biopharmaceutical company focused on the discovery and development
of unique RNA-targeted therapeutics for the treatment of rare
neuromuscular diseases. The Company is primarily focused on rapidly
advancing the development of its potentially disease-modifying DMD
drug candidates. For more information, please visit us at
www.sarepta.com.
Internet Posting of InformationWe routinely post
information that may be important to investors in the 'For
Investors' section of our web site at www.sarepta.com. We
encourage investors and potential investors to consult our website
regularly for important information about us.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161024005693/en/
Media and Investors:Sarepta Therapeutics, Inc.Ian Estepan,
617-274-4052iestepan@sarepta.comorW2O GroupBrian Reid,
212-257-6725breid@w2ogroup.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2023 to Apr 2024
